U.S. RESEARCH ROUNDUP- Allstate, Autozone, Vertex Pharmaceuticals
Sept 23 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Allstate, Autozone and Vertex Pharmaceuticals on Wednesday.
HIGHLIGHTS
* Allstate Corp ALL.N: TD Cowen raises target price to $260 from $231 |
* Autozone, Inc. AZO.N: D.A. Davidson cuts target price to $3,500 from $3,750 |
* Martin Marietta Materials, Inc. MLM.N: Jefferies cuts target price to $670 from $720 |
* Vertex Pharmaceuticals Inc VRTX.O: Jefferies raises target price to $640 from $633 |
* Vulcan Materials Co VMC.N: Jefferies cuts target price to $320 from $345 |
Following is a summary of research actions on U.S. companies reported by Reuters on Wednesday. Stock entries are in alphabetical order.
* Acadia Healthcare Company, Inc. ACHC.O: Leerink Partners raises PT to $33 from $30 |
* Allstate Corp ALL.N: TD Cowen raises target price to $260 from $231 |
* Amgen Inc AMGN.O: Jefferies raises target price to $410 from $367 |
* Anaptysbio, Inc. ANAB.O: Leerink Partners cuts target price to $81 from $90 |
* Anixa Biosciences Inc ANIX.O: H.C. Wainwright cuts target price to $6 from $7 |
* Autozone, Inc. AZO.N: D.A. Davidson cuts target price to $3,500 from $3,750 |
* Autozone, Inc. AZO.N: Exane BNP Paribas cuts target price to $3561 from $3979 |
* Autozone, Inc. AZO.N: Roth MKM cuts target price to $3850 from $4023 |
* Autozone, Inc. AZO.N: TD Cowen cuts target price to $3,400 from $3,500 |
* Bank7 Corp BSVN.O: KBW raises target price to $62 from $56 |
* Carnival Corp CCL.N: Jefferies cuts target price to $33 from $35 |
* Celldex Therapeutics Inc. CLDX.O: Leerink Partners raises target price to $88 from $70 |
* Compass Therapeutics Inc. CMPX.O: Guggenheim cuts target price to $4 from $8 |
* Compass Therapeutics Inc. CMPX.O: Jefferies cuts target price to $3 from $8 |
* Compass Therapeutics Inc. CMPX.O: Wedbush cuts to neutral from outperform |
* Compass Therapeutics Inc. CMPX.O: Wedbush cuts target price to $1 from $5 |
* Cummins CMI.N: JP Morgan cuts target price to $600 from $690 |
* Dauch Corp DCH.N: Jefferies cuts to hold from buy; cuts target price to $7.10 from $8.25 |
* Graphic Packaging Holding Company GPK.N: JP Morgan raises to overweight from neutral |
* Graphic Packaging Holding Company GPK.N: JP Morgan cuts target price to $11.5 from $12.5 |
* Guardian Pharmacy Services Inc GRDN.N: Keybanc initiates with overweight rating; PT $52 |
* KB Home KBH.N: Barclays cuts target price to $49 from $57 |
* KB Home KBH.N: RBC cuts target price to $50 from $53 |
* KB Home KBH.N: Truist Securities cuts target price to $50 from $55 |
* Martin Marietta Materials, Inc. MLM.N: Jefferies cuts target price to $670 from $720 |
* Marvell Technology MRVL.O: Seaport Research Partners initiates with buy rating; PT $270 |
* Merck & Co Inc MRK.N: TD Cowen raises target price to $155 from $137 |
* Onsemi ON.O: Seaport Research Partners initiates coverage with buy rating; PT $100 |
* Semtech Corp SMTC.O: Seaport Research Partners initiates with buy rating; target $200 |
* SiTime Corporation SITM.O: Seaport Research Partners initiates coverage with neutral rating |
* Thor Industries, Inc. THO.N: Jefferies cuts target price to $82 from $90 |
* UiPath Inc PATH.N: RBC cuts target price to $15 from $17 |
* Vertex Pharmaceuticals Inc VRTX.O: Jefferies raises target price to $640 from $633 |
* Viking Therapeutics, Inc. VKTX.O: Oppenheimer raises target price to $120 from $100 |
* Viking Therapeutics, Inc. VKTX.O: Truist Securities raises target price to $87 from $83 |
* Vulcan Materials Co VMC.N: Jefferies cuts target price to $320 from $345 |